Randall Schreck

4.7k citations
13 papers · 2.3k · 1 hit paper · h-index 9

Impact in

Papers in

    • Angiogenesis and VEGF in Cancer 5
    • PI3K/AKT/mTOR signaling in cancer 2
    • Cancer Treatment and Pharmacology 3

Randall Schreck

13 papers receiving 2.2k citations

Randall Schreck's Hit Papers

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. 1999 · 885 citations
8850+9+18Years since publication250500750

Peers

Randall Schreck
Comparison fields: 5 of 89
  • Hepatology 298
  • Cancer Research 469
  • Oncology 686
  • Molecular Biology 1.5k
  • Toxicology 54
Replace Richard Kendall with:
Richard Kendall United States
Karl‐Heinz Thierauch Germany
Jane Kendrew United Kingdom
Raymond M. Shaheen United States
Nila U. Parikh United States
T. Annie T. Fong United States
K. Peter Hirth Germany
Laurent Hennequin France
Jon Curwen United Kingdom
Yoshihiko Kitajima Japan
Randall Schreck relative to Richard Kendall United States Richard Kendall's profile →
Citations per field
00.5×1.5×
Richard Kendall · 1×
Citations per year

Countries citing papers authored by Randall Schreck

Since Specialization
Citations

This map shows the geographic impact of Randall Schreck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall Schreck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall Schreck more than expected).

Fields of papers citing papers by Randall Schreck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall Schreck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall Schreck. The network helps show where Randall Schreck may publish in the future.

Co-authors

The 25 scholars most cited alongside Randall Schreck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Randall Schreck Line = papers co-authored together Randall Schreck links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.
Hit paper breakdown →
1999885
2
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.
2003421
3
Flk-1 as a target for tumor growth inhibition.
1996279
4 1999213
5
The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
2000173
6 200099
7 199498
8
High levels of HER-2 expression alter the ability of epidermal growth factor receptor (EGFR) family tyrosine kinase inhibitors to inhibit EGFR phosphorylation in vivo.
200160
9 199549
10 19897
11 20054
12 20113
13 20062

About Randall Schreck

Randall Schreck is a scholar working on Molecular Biology, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 13 papers that have together received 2.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Cancer Treatment and Pharmacology (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Immune Cell Function and Interaction (2 papers), Microtubule and mitosis dynamics (1 paper) and Animal Nutrition and Physiology (1 paper). The work is most often cited by research in Hepatology (298 citations), Cancer Research (469 citations), Oncology (686 citations), Molecular Biology (1.5k citations) and Toxicology (54 citations). Randall Schreck has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Gerald McMahon, Cho Tang, Li Sun, Laura K. Shawver, Werner Risau, Thomas Powell, Xueyan Wang, K. Peter Hirth, T. Annie T. Fong and A. Ullrich. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology, Clinical Immunology and Journal of Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact